Last reviewed · How we verify

ANTIPYRINE

FDA-approved active Small molecule Under review Quality 10/100

ANTIPYRINE is a Non-Standardized Plant Allergenic Extract [EPC] drug. It is currently FDA-approved for Toothaches, Swollen Gums, Jaw Pain.

Antipyrine is a small molecule that belongs to the drug class of inhibitors. It is a cyclooxygenase-1 inhibitor, which targets the enzyme prostaglandin G/H synthase 1.

At a glance

Generic nameANTIPYRINE
Drug classNon-Standardized Plant Allergenic Extract [EPC]
ModalitySmall molecule
PhaseFDA-approved

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about ANTIPYRINE

What is ANTIPYRINE?

ANTIPYRINE is a Non-Standardized Plant Allergenic Extract [EPC] drug, indicated for Toothaches, Swollen Gums, Jaw Pain.

What is ANTIPYRINE used for?

ANTIPYRINE is indicated for Toothaches, Swollen Gums, Jaw Pain.

What drug class is ANTIPYRINE in?

ANTIPYRINE belongs to the Non-Standardized Plant Allergenic Extract [EPC] class. See all Non-Standardized Plant Allergenic Extract [EPC] drugs at /class/non-standardized-plant-allergenic-extract-epc.

What development phase is ANTIPYRINE in?

ANTIPYRINE is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing